SCHEMBL28019722

SCHEMBL28019722

COc1cccc(-c2cccc([N+](=O)[O-])c2[C]=O)c1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.56
▸ RAB9A P51151 3/20 0.56
▸ CASP3 P42574 2/20 0.56
▸ SENP7 Q9BQF6 1/20 0.56
▸ FBP1 P09467 3/20 0.46
▸ ALDH1A1 P00352 6/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ MAPT P10636 3/20 0.46
▸ TDP1 Q9NUW8 2/20 0.44
▸ EIF4E P06730 1/20 0.44
▸ MAOB P27338 1/20 0.43
▸ LMNA P02545 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ PIN1 Q13526 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30785680 0.87 NPC1 (0.70) NPC1RAB9ACASP3SENP7FBP1
SCHEMBL2957169 0.87 NPC1 (0.70) NPC1RAB9ACASP3SENP7FBP1
SCHEMBL27292647 0.82 RAB9A (0.60) NPC1RAB9ACASP3SENP7FBP1
SCHEMBL3491442 0.81 NPC1 (0.58) NPC1RAB9ACASP3SENP7FBP1
SCHEMBL28019848 0.79 TDP1 (0.47) FBP1ALDH1A1KMT2AMAPTTDP1
SCHEMBL2970853 0.78 ALDH1A1 (0.54) NPC1RAB9ACASP3SENP7FBP1
SCHEMBL7244775 0.77 NPC1 (0.58) NPC1RAB9ACASP3SENP7FBP1
SCHEMBL14469794 0.76 NPC1 (0.51) NPC1RAB9ACASP3SENP7FBP1
SCHEMBL12472637 0.76 NPC1 (0.50) NPC1RAB9ACASP3SENP7FBP1
SCHEMBL3489465 0.74 NPC1 (0.52) NPC1RAB9ACASP3SENP7FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104768952-B PI3K inhibitors 山东亨利医药科技有限责任公司 2016-10-19 — — CN disclosed
CN-104768952-A PI3K inhibitors KBP BIOSCIENCES CO LTD 2015-07-08 — — CN disclosed
Send feedback